| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |